NATERA, INC. Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised
NATERA, INC. (NTRA) reported Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised of $17.30 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans · last filed 2025-02-28
- NATERA, INC. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for the quarter ending 2024-12-31 was $8.44M, a 30.71% increase year-over-year.
- NATERA, INC. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for the quarter ending 2024-09-30 was $0.00.
- NATERA, INC. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for the quarter ending 2023-12-31 was $6.45M, a 42.13% increase year-over-year.
- NATERA, INC. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for the quarter ending 2023-09-30 was $0.00.
- NATERA, INC. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for fiscal 2024 was $17.30M, a 14.34% increase from fiscal 2023.
- NATERA, INC. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for fiscal 2023 was $15.13M, a 16.04% increase from fiscal 2022.
- NATERA, INC. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for fiscal 2022 was $13.04M, a 3.79% decline from fiscal 2021.
- NATERA, INC. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for fiscal 2021 was $13.55M, a 90.47% increase from fiscal 2020.
| Period end | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 3 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 6 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 9 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 12 month |
|---|---|---|---|---|
| 2024-12-31 | $8.44M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $8.44M derived: sum of 2 quarters · filed 2025-02-28 | $17.30M 10-K · filed 2025-02-28 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $8.86M 10-Q · filed 2024-11-12 | ||
| 2024-06-30 | $8.86M 10-Q · filed 2024-08-09 | |||
| 2023-12-31 | $6.45M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $6.45M derived: sum of 2 quarters · filed 2025-02-28 | $15.13M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $8.67M 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | $8.67M 10-Q · filed 2024-08-09 | |||
| 2022-12-31 | $4.54M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $4.54M derived: sum of 2 quarters · filed 2025-02-28 | $13.04M 10-K · filed 2025-02-28 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $8.50M 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $8.50M 10-Q · filed 2023-08-04 | |||
| 2021-12-31 | $7.46M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $7.46M derived: sum of 2 quarters · filed 2024-02-29 | $13.55M 10-K · filed 2024-02-29 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $6.08M 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | $6.08M 10-Q · filed 2022-08-05 | |||
| 2020-12-31 | $4.05M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $4.05M derived: sum of 2 quarters · filed 2023-03-01 | $7.11M 10-K · filed 2023-03-01 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $3.06M 10-Q · filed 2021-11-05 | ||
| 2020-06-30 | $3.06M 10-Q · filed 2021-08-06 | |||
| 2019-12-31 | $2.18M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $4.32M derived: sum of 2 quarters · filed 2022-02-25 | $6.47M derived: sum of 3 quarters · filed 2022-02-25 | $4.32M 10-K · filed 2022-02-25 |
| 2019-09-30 | $2.15M 10-Q · filed 2020-11-06 | $4.29M derived: sum of 2 quarters · filed 2020-11-06 | $2.15M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $2.15M 10-Q · filed 2020-08-07 | $2.15M 10-Q · filed 2019-08-09 | ||
| 2018-12-31 | $1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $1.76M derived: sum of 2 quarters · filed 2021-02-26 | $3.62M 10-K · filed 2021-02-26 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $1.85M 10-Q · filed 2019-11-08 | ||
| 2018-06-30 | $1.85M 10-Q · filed 2019-08-09 | |||
| 2017-12-31 | $3.34M 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |